Evidence map›Paper›PMID 32171526›Full record

ArticleBiochemical and biophysical research communications2020

The role of propofol hydroxyl group in 5-lipoxygenase recognition.

Koichi Yuki, Weiming Bu, Roderic G Eckenhoff, Takehiko Yokomizo, Toshiaki Okuno

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Propofol directly binds to and inhibits TLR7.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Koichi YukiDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Anaesthesia, Harvard Medical School, Boston, MA, 02115, USA. Electronic address: koichi.yuki@childrens.harvard.edu.
Weiming BuDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Roderic G EckenhoffDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Takehiko YokomizoDepartment of Biochemistry, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Toshiaki OkunoDepartment of Biochemistry, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, 113-8421, Japan. Electronic address: tokuno@juntendo.ac.jp.
Juntendo University · JPUniversity of Pennsylvania · USBoston Children's Hospital · US

Funding

The impact of anesthetic selection on sepsis outcome and its mechanismR01GM118277 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI YUKI, KOICHI · 2016 to 2020
$1.8M
NIGMS NIH HHS R01 GM118277
6 · The paper itself

Abstract

Propofol is a clinically important intravenous anesthetic. We previously reported that it directly inhibited 5-lipoxygenase (5-LOX), a key enzyme for leukotriene biosynthesis. Because the hydroxyl group in propofol (propofol 1-hydroxyl) is critical for its anesthetic effect, we examined if its presence would be inevitable for 5-lipoxygenase recognition. Fropofol is developed by substituting the hydroxy group in propofol with fluorine. We found that propofol 1-hydroxyl was important for 5-lipoxygenase recognition, but it was not absolutely necessary. Azi-fropofol bound to 5-LOX at one of the two propofol binding sites of 5-LOX (pocket around Phe-187), suggesting that propofol 1-hydroxyl is important for 5-LOX inhibition at the other propofol binding site (pocket around Val-431). Interestingly, 5-hydroperoxyeicosatetraenoic acid (5-HpETE) production was significantly increased by stimulation with calcium ionophore A23187 in HEK293 cells expressing 5-LOX, suggesting that the fropofol binding site is important for the conversion from 5-HpETE to leukotriene A

Indexed as

Anesthetics, IntravenousArachidonate 5-LipoxygenaseArachidonic AcidBinding SitesCalcimycinCalcium IonophoresHEK293 CellsHumansLeukotriene B4LeukotrienesLipoxygenase InhibitorsMolecular Docking SimulationMutagenesisPropofolProtein ConformationStructure-Activity RelationshipAnesthetics, IntravenousArachidonate 5-LipoxygenaseArachidonic Acidarachidonic acid 5-hydroperoxideCalcimycinCalcium IonophoresLeukotriene B4LeukotrienesLipoxygenase InhibitorsPropofol5-lipoxygenaseFropofolPropofolPropofol 1-hydroxyl

Identifiers

PMID32171526
PMCPMC7167355
OpenAlexW3012485831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.